$5.88
Last update: Nov 12, 4:00 PM
Trinity Biotech PLC
TRIBNASDAQ
Trinity Biotech fell 77.6% from $25.97 to $5.82, behind the S&P 500's +12.7%. Its worst day was Jun 23 (−39.0%), and its low came Nov 9 at $5.28.
Nov 13, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.28 beat the $-0.32 estimate on $14.3M revenue (est. $15.0M).
+43.5%, the year's best day, on 6M shares, the year's heaviest volume · S&P 500 +0.5%
EPS of $-0.90 missed the $-0.31 estimate on $11.1M revenue.
Story events cover the past 12 months · Times ET
−1.7% · S&P 500 −0.3%
EPS of $-0.23 was reported on $10.8M revenue.
−15.8% · S&P 500 −0.6%
Trinity Biotech shares rose 35.0%, while the S&P 500 rose 0.2%.
+35.0% · S&P 500 +0.2%
Trinity Biotech shares rose 23.7%, while the S&P 500 rose 0.5%.
+23.7% · S&P 500 +0.5%
Trinity Biotech shares rose 27.7%, while the S&P 500 rose 0.3%.
+27.7% · S&P 500 +0.3%
Where it ended: a close of $5.82 on Nov 11, 2026. Up next: Q3 2026 earnings on Dec 22, 2026.
Nothing in the past 12 months.
All TRIB analyst actionsNothing in the past 12 months.
All TRIB dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TRIB and SPY from Benzinga historical bars. Not investment advice.
